Reviews in Gastrointestinal and Hepatic Pharmacology: 2024

11k
Total downloads
46k
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Accepted on 29 Sep 2025

The use of Magnesium Sulfate can reduce the mortality risk of cirrhosis patients: A Retrospective Cohort Study

Boxian Chen
Yuping Yang
Mouji Liang
Zhe Huang
Shicai Ye
Yujie Huang
Ruyin Ye
Liping Zhan
Yanqi Kou
2 more
Haoyuan Huang

doi 10.3389/fphar.2025.1551495

528 views

SYSTEMATIC REVIEW

Published on 11 Aug 2025

Potential of ciprofol as an alternative to propofol in elderly patients undergoing gastrointestinal endoscopy: a meta-analysis and trial sequential analysis

Yunfeng Yu
Min Liao
Juan Deng
Xinyu Yang
Yuman Yin
Zhenjie Liu
Guomin Zhang

doi 10.3389/fphar.2025.1644182

1,120 views

ORIGINAL RESEARCH

Published on 29 Jul 2025

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC

Bowen Liu
Linan Yin
Yuxin Chen
Xunbo Hou
Yingchen Li
Xuesong Liu
Ruibao Liu

doi 10.3389/fonc.2025.1615506

1,143 views

GENERAL COMMENTARY

Published on 07 Jul 2025

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

Yingjie Liu
Keying Wang
Wenjiang Wu

doi 10.3389/fphar.2025.1625961

1,032 views

REVIEW

Published on 22 May 2025

Pharmacological potential of endocannabinoid and endocannabinoid-like compounds in protecting intestinal structure and metabolism under high-fat conditions

Francesco Vari
Ilaria Serra
Marzia Friuli
Viviana Cavallo
Nicola Gammaldi
Daniele Vergara
Michel Salzet
Anna M. Giudetti

doi 10.3389/fphar.2025.1567543

1,871 views

REVIEW

Published on 21 May 2025

Vitamin B5 and vitamin U review: justification of combined use for the treatment of mucosa-associated gastrointestinal pathologies

Valentin P. Shichkin

doi 10.3389/fphar.2025.1587627

5,117 views
2 citations

REVIEW

Published on 22 Apr 2025

Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatment

Xinyue Cui
Quanhao Sun
Haiqiang Wang

doi 10.3389/fphar.2025.1510322

3,741 views
2 citations

REVIEW

Published on 07 Apr 2025

Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression

Roohi Chaudhary
Ralf Weiskirchen
Marcelo Ehrlich
Yoav I. Henis

doi 10.3389/fphar.2025.1580500

3,442 views
3 citations

REVIEW

Published on 27 Mar 2025

Mechanism and therapeutic potential of liver injury induced by cholesterol-associated proteins

Yourong Zhou
Yashi Cao
Yiming Yin
Zhifei Xu
Xiaochun Yang
Bo Yang
Peihua Luo
Hao Yan
Qiaojun He

doi 10.3389/fphar.2025.1572592

1,433 views
2 citations

REVIEW

Published on 21 Mar 2025

Recent advancement in prevention against hepatotoxicity, molecular mechanisms, and bioavailability of gallic acid, a natural phenolic compound: challenges and perspectives

Peng Chen
Fanzhao Zou
Wei Liu

doi 10.3389/fphar.2025.1549526

2,487 views
3 citations

REVIEW

Published on 23 Jan 2025

Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease

Wei Xuan
Dandan Song
Jianghua Hou
Xiuping Meng

doi 10.3389/fphar.2025.1505117

2,396 views
2 citations

SYSTEMATIC REVIEW

Published on 09 Jan 2025

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease

Haohang Su
Shengwei Xiao
Zhiqing Liang
Tianrong Xun
Jinfang Zhang
Xixiao Yang

doi 10.3389/fphar.2024.1475222

4,179 views
1 citation

Share on

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

46kTopic views
33kArticle views
11kArticle downloads

View impact